Consumers Union commends the Senate Finance Committee for its recent work uncovering FDA delays in acting against potentially dangerous prescription drugs – most notably Vioxx – despite growing evidence of unreasonable safety risks.
Consumers Union commends the Senate Finance Committee for its recent work uncovering FDA delays in acting against potentially dangerous prescription drugs – most notably Vioxx – despite growing evidence of unreasonable safety risks.